Cefotetan versus cefoxitin in the treatment of patients with biliary sepsis assessed by a biliary sepsis score.
Basoli
A
A
2nd Surgical Unit, VI Surgical Department, University La Sapienza , Rome, Italy.
Schietroma
M
M
Fiocca
F
F
Vigliardi
G
G
Speranza
V
V
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001420:Bacteria, Aerobic / Q000187:drug effects / Q000302:isolation & purification; D001421:Bacteria, Anaerobic / Q000187:drug effects / Q000302:isolation & purification; D001831:Body Temperature; D015313:Cefotetan / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002440:Cefoxitin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005705:Gallbladder Diseases / Q000188:drug therapy / Q000382:microbiology*; D006207:Half-Life; D006801:Humans; D018805:Sepsis / Q000150:complications / Q000188:drug therapy*; D012772:Shock, Septic / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D015313:Cefotetan; D002440:Cefoxitin